XML 43 R32.htm IDEA: XBRL DOCUMENT v3.25.1
Earnings (Loss) Per Share (Tables)
9 Months Ended
Mar. 31, 2025
Earnings (Loss) Per Share  
Schedule of earnings per shares

 

 

Three Months Ended
March 31,

 

 

Nine Months Ended
March 31,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$(3,582,460)

 

$(2,597,534)

 

$(7,817,202)

 

$(5,653,573)

Accretion of dividends on Series G preferred

 

 

(14,751,134)

 

 

 —

 

 

 

(14,751,134)

 

 

 —

 

Net loss attributable to stockholders

 

$(18,333,594)

 

$(2,597,534)

 

$(22,568,336)

 

$(5,653,573)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average common shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic number of shares

 

 

41,363,643

 

 

 

37,988,770

 

 

 

40,209,657

 

 

 

37,639,464

 

Diluted number of shares

 

 

41,363,643

 

 

 

37,988,770

 

 

 

40,209,657

 

 

 

37,639,464

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss per common share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$(0.44)

 

$(0.07)

 

$(0.56)

 

$(0.15)

Diluted

 

$(0.44)

 

$(0.07)

 

$(0.56)

 

$(0.15)
Schedule of potential dilutive shares

 

 

Three Months Ended

March 31,

 

 

Nine Months Ended

March 31,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Options to purchase common stock

 

 

394,527

 

 

 

540,123

 

 

 

486,965

 

 

 

536,335

 

RSUs and RSAs

 

 

1,131,004

 

 

 

1,981,071

 

 

 

1,285,881

 

 

 

1,790,148

 

Series G convertible preferred, warrants & convertible notes

 

 

2,890,176

 

 

 

 

 

 

935,057

 

 

 

 

 

 

 

4,415,707

 

 

 

2,521,194

 

 

 

2,707,903

 

 

 

2,326,483